To secure the future of research on rare genetic diseases, we established two Institutes in Italy, now internationally recognized as centers of excellence. They bring together leading scientists, hospitals, academia, and industry in a collaborative ecosystem that drives innovation from discovery to pioneering therapies.
542
professional resources
15,2 millions
2024 investment on Tigem
15,6 millions
2024 investment on SR-Tiget
A joint venture between Fondazione Telethon and Ospedale San Raffaele (Milan), SR-Tiget is world-recognized centre of excellence for research and clinical translation of advanced therapies.
Based in the former Olivetti factory building (Pozzuoli), Tigem is a research institute focused on studying the mechanisms underlying genetic diseases and on developing innovative therapeutic strategies.
